Landing
European Society of Retina Specialists (EURETINA) 2025
Impact of AREDS Oral Micronutrient Supplementation on Geographic Atrophy Progression: Insights from the Phase 3 OAKS and DERBY Trials
Early Versus Delayed Pegcetacoplan Treatment for GA Secondary to AMD: 48 Month Results from OAKS, DERBY, and GALE Open-Label Extension
Factors Affecting Geographic Atrophy Progression and Treatment Response to Pegcetacoplan
Can visual acuity be estimated from multimodal imaging of geographic atrophy (GA) in age-related macular degeneration (AMD)?
AI-Powered Assessment of Retinal Function: From OCT to High-Definition Sensitivity Maps
Machine-learning derived quantitative SD-OCT biomarkers of photoreceptor- and RPE-integrity are predictive of microperimetry outcomes in the OAKS trial
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.